Autopsy report · NCT03246113

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

“Lack of subject interest due to study design”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 1 year 2 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

New York State Psychiatric Institute

Sponsor type

University, hospital or other

Conditions

Glioblastoma

Interventions

Cannabis; Temozolomide; Radiation Therapy

Participants

1

Sites

2

Countries

United States

Trials that died the same way

• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
  “Study design was inadequate and would not achieve study endpoints” (69% match in meaning)
• Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses
  “New study design will be made” (68% match in meaning)
• Infliximab Top-down in Pediatric Crohn
  “Not enough study subjects” (67% match in meaning)
• Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury
  “Lack of study participants.” (65% match in meaning)
• PK Intravenous Lidocaine Infusion
  “Lack of available study participants.” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.